Dyne Therapeuticsinc Stock Return On Equity
| DYN Stock | USD 24.82 0.19 0.77% |
Dyne TherapeuticsInc fundamentals help investors to digest information that contributes to Dyne TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Dyne Stock. The fundamental analysis module provides a way to measure Dyne TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dyne TherapeuticsInc stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (2.58) | (2.46) |
Dyne | Return On Equity |
Dyne TherapeuticsInc Company Return On Equity Analysis
Dyne TherapeuticsInc's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Dyne TherapeuticsInc Return On Equity | -1.37 |
Most of Dyne TherapeuticsInc's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dyne TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Dyne Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Dyne TherapeuticsInc is extremely important. It helps to project a fair market value of Dyne Stock properly, considering its historical fundamentals such as Return On Equity. Since Dyne TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dyne TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dyne TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Dyne Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Dyne TherapeuticsInc has a Return On Equity of -1.3731. This is 94.27% lower than that of the Biotechnology sector and 96.23% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Dyne Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dyne TherapeuticsInc's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dyne TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Dyne TherapeuticsInc by comparing valuation metrics of similar companies.Dyne TherapeuticsInc is currently under evaluation in return on equity category among related companies.
Dyne Fundamentals
| Return On Equity | -1.37 | ||||
| Return On Asset | -0.64 | ||||
| Current Valuation | 1.99 B | ||||
| Shares Outstanding | 86.18 M | ||||
| Shares Owned By Insiders | 0.90 % | ||||
| Shares Owned By Institutions | 86.04 % | ||||
| Number Of Shares Shorted | 8.08 M | ||||
| Price To Earning | 35.58 X | ||||
| Price To Book | 24.40 X | ||||
| EBITDA | (239.7 M) | ||||
| Net Income | (235.94 M) | ||||
| Cash And Equivalents | 291.84 M | ||||
| Cash Per Share | 5.64 X | ||||
| Total Debt | 27.41 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 11.63 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (188.16 M) | ||||
| Short Ratio | 4.31 X | ||||
| Earnings Per Share | (3.95) X | ||||
| Price To Earnings To Growth | 0.19 X | ||||
| Target Price | 37.75 | ||||
| Number Of Employees | 141 | ||||
| Beta | 0.95 | ||||
| Market Capitalization | 2.19 B | ||||
| Total Asset | 165.08 M | ||||
| Retained Earnings | (632.51 M) | ||||
| Working Capital | 78.28 M | ||||
| Current Asset | 1.93 B | ||||
| Current Liabilities | 809 M | ||||
| Net Asset | 165.08 M |
About Dyne TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dyne TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyne TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyne TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Dyne TherapeuticsInc Investors Sentiment
The influence of Dyne TherapeuticsInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dyne. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dyne TherapeuticsInc's public news can be used to forecast risks associated with an investment in Dyne. The trend in average sentiment can be used to explain how an investor holding Dyne can time the market purely based on public headlines and social activities around Dyne TherapeuticsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dyne TherapeuticsInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dyne TherapeuticsInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dyne TherapeuticsInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dyne TherapeuticsInc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dyne TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dyne TherapeuticsInc's short interest history, or implied volatility extrapolated from Dyne TherapeuticsInc options trading.
Pair Trading with Dyne TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
| 0.69 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
Moving against Dyne Stock
| 0.79 | BIIB | Biogen Inc Earnings Call This Week | PairCorr |
| 0.77 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.68 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.49 | ABVC | ABVC Biopharma | PairCorr |
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dyne TherapeuticsInc Piotroski F Score and Dyne TherapeuticsInc Altman Z Score analysis. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Return On Assets (0.64) | Return On Equity (1.37) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.